This application seeks to investigate potential behavioral economic markers of prescription opioid addiction in patients with chronic, non-cancer pain. Drawing from previous studies of behavioral economic mechanisms of drug use, Aim 1 will validate a novel laboratory procedure to examine pain-related prescription opioid demand in chronic pain patients who misuse prescribed opioid medications (n =30). A novel opioid purchase task will assess prescription opioid demand under conditions of experimentally-induced pain, and will be validated against an established laboratory task of opioid reinforcement.
Aim 2 will utilize a randomized, within-subjects design to compare behavioral economic markers in two groups of patients with chronic pain: 1) those with current prescription opioid addiction (n = 40), and 2) a control group of patients with low opioid misuse risk and no history of opioid or other drug addiction (n = 40). Patients with prescription opioid addiction are expected to exhibit greater delay discounting and prescription opioid demand compared to controls. This research will validate novel experimental methodology and provide initial data on behavioral economic mechanisms of prescription opioid addiction in chronic pain patients. The candidate is a clinical psychologist with an early track record of research productivity in mechanisms of substance use and behavioral interventions in adults with co-occurring disorders. This K23 will provide him with necessary methodological and substantive training to support his long-term research goal of identifying neurobehavioral mechanisms of risk for prescription opioid addiction in patients with chronic pain. The candidate's short-term objectives are to acquire methodological skills in behavioral economics, develop mastery in opioid pharmacology, increase his expertise in the neurobiology of addiction, and gain knowledge in the neurocognitive mechanisms of chronic pain and experimental pain methodology. The candidate will be mentored by senior investigators with expertise in each of these domains. He is supported by the institutional resources of the Center for Behavioral and Addiction Medicine at UCLA, an environment well-suited for the purpose of research in chronic pain and addictions via the integration of addiction medicine into primary care settings. The proposed research and training will equip the candidate with unique expertise in the overlapping and mechanistic neurobehavioral processes implicated in chronic pain, addictive behavior, and reward processing, with the long-term goal of establishing an independent laboratory conducting NIH-funded research in this area.

Public Health Relevance

National trends in the use and abuse of prescription opioid medications have increased dramatically and many individuals who develop prescription opioid addiction have chronic pain. The neurobehavioral mechanisms that contribute to prescription opioid addiction in chronic pain patients have not been established. This project will investigate the association between established behavioral economic markers of addictive behavior and prescription opioid addiction in chronic pain patients.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23DA039348-01A1
Application #
8968077
Study Section
Risk, Prevention and Intervention for Addictions Study Section (RPIA)
Program Officer
Lin, Yu
Project Start
2016-04-01
Project End
2021-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Psychiatry
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Worley, Matthew J; Swanson, Aimee-Noelle; Heinzerling, Keith G et al. (2018) Corrigendum to ""Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study"" [Drug Alcohol Depend. 162 (2016) 245-250]. Drug Alcohol Depend 190:120
Granholm, Eric; Holden, Jason; Worley, Matthew (2018) Improvement in Negative Symptoms and Functioning in Cognitive-Behavioral Social Skills Training for Schizophrenia: Mediation by Defeatist Performance Attitudes and Asocial Beliefs. Schizophr Bull 44:653-661
Nguyen-Louie, Tam T; Brumback, Ty; Worley, Matthew J et al. (2018) Effects of sleep on substance use in adolescents: a longitudinal perspective. Addict Biol 23:750-760
Courtney, Kelly E; Worley, Matthew; Castro, Norma et al. (2018) The effects of alcohol hangover on future drinking behavior and the development of alcohol problems. Addict Behav 78:209-215
Roche, Daniel J O; Worley, Matthew J; Courtney, Kelly E et al. (2017) Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology (Berl) 234:1997-2007
Isgro, Melodie; Doran, Neal; Heffner, Jaimee L et al. (2017) Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men. J Stud Alcohol Drugs 78:232-240
Anthenelli, Robert M; Heffner, Jaimee L; Wong, Esther et al. (2017) A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men. Alcohol Clin Exp Res 41:197-206
Worley, Matthew J; Heinzerling, Keith G; Shoptaw, Steven et al. (2017) Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction 112:1202-1209
Luk, Jeremy W; Worley, Matthew J; Winiger, Evan et al. (2016) Risky driving and sexual behaviors as developmental outcomes of co-occurring substance use and antisocial behavior. Drug Alcohol Depend 169:19-25
Brumback, T Y; Worley, Matthew; Nguyen-Louie, Tam T et al. (2016) Neural predictors of alcohol use and psychopathology symptoms in adolescents. Dev Psychopathol 28:1209-1216